Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS

Illustration of young woman standing in front of exit door

Layoffs

Alector Cuts Staff Again, This Time Laying Off 13% of Workforce

As part of cost-cutting efforts, Alector is letting go of about 25 people as it focuses on advancing its preclinical and research pipeline. Alector is also continuing clinical-stage work on programs for frontotemporal dementia and Alzheimer’s disease.

March 25, 2025

2 min read

Angela Gabriel

Businessmen working together installing gears in human head, business initiative, mindset improvement concept

Vaccines

GSK Builds on Real-World Experiment to Study Shingrix’s Impact on Dementia

The British pharmaceutical giant is working with the U.K. Dementia Research Institute to exploit a “natural randomization” experiment to determine whether 65- and 66-year-olds who received GSK’s shingles vaccine Shingrix have reduced dementia risk.

March 25, 2025

1 min read

Dan Samorodnitsky

Illustration showing hands holding arrow that goes up and down a few times and ends up in upward direction

Compensation

Average Life Sciences Salaries Up 9% in 2024, but Bonuses and Equity Values Drop: BioSpace Report

The 9% average salary increase from 2023 to 2024 was the largest for life sciences professionals since 2021. Several factors could be behind the spike, including companies providing higher pay because bonuses and stock compensation went down.

March 25, 2025

3 min read

Angela Gabriel

Online Vertebrologist ,Orthopedics Woman traumatologist Surgeon Doctor.Internet Presentation Seminar.Fracture, Pain in Back Spine Diagnostics.Internet Conference. Digital Medical Hospital Illustration

Immunology and inflammation

Hillstar Bio Nets $67M Series A to Advance Autoimmune and Arthritis Pipeline

Led by alums from Takeda and Boston Pharmaceuticals, Hillstar Bio is working on treatments that remove harmful immune cells to relieve disease.

March 25, 2025

2 min read

Dan Samorodnitsky

South San Francisco, CA, USA - May 1, 2022: Exterior view of the Merck Researches Laboratories in South San Francisco, California. Merck & Co., Inc. is a global pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme (MSD) outside the United States and Canada.

Collaboration

Merck Commits Nearly $2B for Oral Lipid-Lowering Drug from Chinese Biotech

Merck joins a growing list of companies targeting lipoprotein(a), high levels of which are associated with an elevated risk of adverse cardiovascular outcomes.

March 25, 2025

2 min read

Tristan Manalac

Sale discounts and promotions. Loans and mortgages. Cashback shopping bonus. Rising borrowing payments

Policy

Trump Doubles Down on Pharma Tariff Threats

President Donald Trump’s tariffs on pharmaceuticals “to come at some point,” per CNBC, as companies promise to build infrastructure in the U.S.

March 25, 2025

2 min read

Tristan Manalac

Glasses and lenses for correcting vision on a colored background. High quality photo

Drug development

Opthea, UNITY Fail to Unseat Regeneron’s Eylea in Vision Disorders

The Eylea franchise was in need of a win after an appellate court last week denied the pharma’s bid to block Amgen’s biosimilar from the U.S.

March 25, 2025

2 min read

Tristan Manalac

CDC approved vaccines for adults to boost the immu

Government

Trump Nominates Acting Director Monarez as CDC Head

If confirmed, Susan Monarez will have her work cut out for her, facing a measles outbreak that has already killed two people—the first measles-related deaths in the U.S. since 2015.

March 25, 2025

2 min read

Tristan Manalac